MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 4 filers reported holding MANNKIND CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AYM CAPITAL, LLC | 1,305,000 | $7,713,000 | 5.61% |
| Greywolf Capital Management LP | 6,206,570 | $36,681,000 | 4.08% |
| AYM CAPITAL, LLC | 692,300 | $4,092,000 | 2.98% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,412,600 | $8,348,000 | 2.26% |
| B. Riley Wealth Advisors, Inc. | 1,238,880 | $7,322,000 | 1.11% |
| ZEKE LP /PA | 50,000 | $295,000 | 1.06% |
| Old West Investment Management, LLC | 266,566 | $1,575,000 | 0.99% |
| Cohen Capital Management, Inc. | 500,000 | $2,955,000 | 0.79% |
| Tourbillon Capital Partners, L.P. | 3,250,000 | $19,208,000 | 0.70% |
| Adamant Biomedical Investments AG | 300,000 | $1,773,000 | 0.44% |